Our analysis showed that miR-150 (also reduced in the serum of the HNSCC patients) appears to target several genes involved in the regulation of cell growth and division such as PIM1 and EP300 (Figure 4). This evidence concerns the gene EP300 and head and neck squamous cell carcinoma.